Page last updated: 2024-11-07

rmi 15731

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

RMI 15731: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID100549
CHEMBL ID3273833
SCHEMBL ID8413515
MeSH IDM0076776

Synonyms (20)

Synonym
nsc317936
nsc-317936
54857-96-4
1-(5-(tetradecyloxy)-2-furanyl)ethanone
rmi 15,731
1-(5-tetradecoxy-2-furyl)ethanone
rmi-15731
rmi 15731
unii-47e4gm277b
47e4gm277b ,
nsc 317936
CHEMBL3273833
5-(tetradecyloxy)-2-furyl methyl ketone
MMOTUYBUAZJWRU-UHFFFAOYSA-N
1-(5-tetradecyloxy-2-furanyl)ethanone
SCHEMBL8413515
ethanone, 1-(5-(tetradecyloxy)-2-furanyl)-
DTXSID20203339
Q27259048
PD161547
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1147276Hypolipidemic activity in Wistar rat assessed as reduction in plasma cholesterol level at 499 umol/kg/day administered through diet for 4 days1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
AID1147175Hypolipidemic activity in Wistar rat assessed as reduction in plasma triglyceride level at 499 umol/kg/day administered through diet for 4 days1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
AID1147364Increase in liver weight in Wistar rat at 499 umol/kg/day administered through diet for 4 days1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.66 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]